Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Aspen raises a $140M IPO in pursuit of a cell therapy for Parkinson’s

The San Diego biotechnology startup is one of several firms working on a cutting-edge technique with the potential to slow or even halt the neurodegenerative condition.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Finance & Markets

More from Friday 30 October →